INTRODUCTION {#cesec10}
============

It has been estimated that around 630,000 people are living with HIV or AIDS in Brazil and, according to the parameters of the World Health Organization, this country has one of the highest concentrations of the epidemic, with a prevalence of HIV infection of 0.61% among the population aged 15 to 49 years[@bib1].

The treatments available do not provide a cure and present variable efficiency and adverse effects. Thus, prevention is the best method of avoiding HIV infection and AIDS, and their consequences.

Studies have indicated that the prevalence of osteoarticular alterations among patients living with HIV/AIDS is high, and that the presence of the virus and highly active antiretroviral therapy are independent risk factors that are boosted by associated metabolic and immunological disorders[@bib2], [@bib3].

Osteonecrosis of the femoral head has an estimated annual incidence of 4% in this population, and mean bilaterality of 57%. This is of concern because it affects a young group of patients, between their fourth and fifth decades of life, and presents evolution to collapse of the head and permanent partial incapacity in 80% of the cases that have had the disease for four years[@bib3], [@bib4], [@bib5], [@bib6], [@bib7].

The diagnosis is suspected based on the patient\'s history and appropriate physical examination, and early diagnosis is achieved by means of investigation using magnetic resonance imaging[@bib3].

The treatment options, which depend on the stage of evolution of the disease, include: motor physiotherapy to maintain joint movement and strengthen muscles; removal of weight-bearing from the affected limb; drug therapy using bisphosphonates; electrical therapy; bone decompression; and partial or total joint replacement[@bib3], [@bib4], [@bib5].

The present authors recently performed 12 total hip arthroplasty procedures secondary to osteonecrosis of the femoral head in patients living with HIV/AIDS. This article is based on our experience and focuses on the preoperative planning, care during the surgical procedure, postoperative complications and initial results from follow-up of more than 12 months.

MATERIALS AND METHODS {#cesec20}
=====================

After obtaining approval from the Scientific Committee of the Institute of Orthopedics and Traumatology (IOT), University of São Paulo (USP), and from the Ethics Committee of Hospital das Clínicas, USP, under number 0606/08, 12 HIV-positive patients who were being followed up as cases of hip osteonecrosis were operated by the Osteo-HIV group of IOT-HC-FMUSP between September and December 2009.

The inclusion criteria were the following: 1) positive serological test for HIV; 2) adherence to antiretroviral treatment at state care centers; 3) clinical release for the procedure after infectology assessment; 4) symptomatic hip osteonecrosis confirmed by means of magnetic resonance imaging; and 5) loss of sphericity of the femoral head.

All the patients underwent assessment of the clinical and laboratory criteria and measurement of the WOMAC score[@bib8].

All the patients were operated in lateral decubitus under regional anesthesia (spinal anesthesia). The route used was the Hardinge lateral approach[@bib9], by means of dissection of the tendons of the gluteus medius and vastus lateralis muscles. The joint capsule was preserved in all the procedures. The mean duration of the procedures was 122 minutes (range: 80 to 155 minutes).

The implants used were uncemented total prostheses, with a Summit nail, Pinnacle acetabulum and joint surfaces (in the acetabulum and femoral head) made of ceramic, zirconium and alumina (Johnson & Johnson^®^).

There were no intraoperative difficulties. Dissection of the soft tissues was facilitated by the small thickness of the adipose layer, a frequent characteristic of this population, which enabled adequate joint exposure through a small surgical incision. Manipulation of the bone tissue did not present indications of fragility with regard to cutting, milling and implant fixation ([Figures 1](#fig1){ref-type="fig"}, [2](#fig2){ref-type="fig"} and [3](#fig3){ref-type="fig"}).

The acetabular component and the femoral nail were implanted under pressure (press fit), and complementary screws were used in the acetabulum in order to allow immediate loading ([Figures 4](#fig4){ref-type="fig"} and [5](#fig5){ref-type="fig"}).

Bone tissue from the femoral head, acetabulum and joint capsule were sent for anatomopathological examination and culturing to test for aerobic and anaerobic bacteria, fungi and mycobacteria.

A double-lumen Porto-Vac^®^ drain of size 3.2 was used in all the patients and was removed on the second postoperative day. Standardized antimicrobial prophylaxis was used, consisting of 1.5 g of intravenous cefuroxime (Zinacef^®^) every 12 hours for 24 hours.

The patients were kept with an abduction pad on the lower limbs until the first day after the operation. Physiotherapy was started immediately after the operation, while avoiding active adduction of the hip for three weeks.

The mean length of hospital stay was four days, and there was no need for support in an intensive care unit.

The patients were released for progressive partial loading on the first day after the arthroplasty, and full loading was reached in three weeks.

Low molecular weight heparin (Clexane^®^) at a dose of 40 mg/day was used for 21 days in order to prevent thromboembolic events.

The stitches were removed at the first outpatient return visit, 10 days after the operation. Outpatient follow-ups were done 10 days, one month, three months and six months after the surgery.

[Table 1](#tbl1){ref-type="table"} describes the laboratory data, disease history and use of antiretroviral medication among the sample.

[Chart 1](#chart1){ref-type="boxed-text"} describes the demographic characteristics, means of the laboratory findings, disease history and use of antiretroviral medication.

RESULTS {#cesec30}
=======

The patients' mean WOMAC scores before the operation and six and twelve months after the operation were respectively 64.2, 19.3 and 10.3, as shown in [Chart 2](#chart2){ref-type="boxed-text"}.

DISCUSSION {#cesec40}
==========

Avascular necrosis of the femoral head is a disease secondary to compromising of the vascular system of the proximal region of the femur. Although many patients do not present any specific identified etiological factor, the risk factors and conditions have been well determined in the literature[@bib10].

The incidence of osteonecrosis of the femoral head in the general population ranges from 0.010 to 0.135%, while in the HIV-positive population it ranges from 1.33 to 4.4%[@bib3], [@bib11], [@bib12].

The Osteo-HIV service of the Institute of Orthopedics and Traumatology of USP had 983 patients under follow-up; 11% of this group presented complaints relating to the coxofemoral joint, and 65 patients were treated for avascular necrosis of the femoral head.

Among patients living with HIV, viral infection and antiretroviral therapy are independent risk factors. The presence of hypertriglyceridemia, anticardiolipin antibodies and lipodystrophic syndrome and use of protease inhibitors increase the risk of developing osteonecrosis[@bib3], [@bib4], [@bib5].

In the sample presented, we found that 83.3% were using protease inhibitors, 75% had dyslipidemia and 66.6% had lipodystrophic syndrome, and these findings were concordant with data in the literature.

The surgical technique used was the Hardinge approach. Despite the high prevalence of osteopenia and osteoporosis in this population of patients, we did not observe any technical difficulty in implanting the prosthetic components, and the osseointegration observed in the outpatient control radiographs presented normal patterns[@bib13], [@bib14], [@bib15], [@bib16].

The patients' young age group, high demand on the joints and risk of harm to renal function due to release of metal particles explain why joint surfaces made of ceramic and uncemented acetabular and femoral components made of porous metal are chosen. These characteristics provide high durability for the implants, with preservation of the bone stock, longer intervals until surgical revision is needed, low production of joint metalosis, low incidence of aseptic loosening and low systemic and local risks[@bib12], [@bib17], [@bib18].

The decreases in WOMAC score among these patients, six and twelve months after the operation, demonstrate that there were significant improvements regarding pain, locomotor function and quality of life. Moreover, these indicate postoperative evolution that is as fast as or faster than that of the general population, possibly due to the young age group of the sample of the present study[@bib19], [@bib20], [@bib21].

We did not observe any postoperative complications, although data in the literature indicate infection rates after this procedure in patients living with HIV ranging from 14 to 1.85%[@bib6], [@bib22], [@bib23].

CONCLUSION {#cesec50}
==========

Total hip arthroplasty using a ceramic-ceramic implant to treat avascular necrosis of the hip in HIV--positive patients with a collapsed femoral head was shown to be an adequate surgical option, presenting significant initial functional improvement and a low early complication rate.
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![Joint exposure of the left hip showing high degree of compromising of the femoral head.](gr1){#fig1}

![Acetabular surface after milling.](gr2){#fig2}

![Placement of the femoral nail under pressure (press fit).](gr3){#fig3}

![Anteroposterior radiograph of the left hip showing fixation of the femoral and acetabular components.](gr4){#fig4}

![Expanded anteroposterior radiographic view of the left hip showing good metaphyseal fixation of the femoral nail and distribution of the fixation screws of the acetabular component.](gr5){#fig5}

###### 

Distribution of the laboratory parameters, periods of disease duration and use of antiretroviral medication among the sample.

  (months)     CD4 (cell/mm^3^)   Disease duration (months)   Viral load (copies/mL)   Duration of medication use
  ------------ ------------------ --------------------------- ------------------------ ----------------------------
  Patient 1    415                120                         \< 50                    120
                                                                                       
  Patient 2    373                84                          \< 50                    82
                                                                                       
  Patient 3    563                164                         Undetectable             121
                                                                                       
  Patient 4    290                180                         Undetectable             132
                                                                                       
  Patient 5    892                168                         60                       168
                                                                                       
  Patient 6    614                132                         Undetectable             132
                                                                                       
  Patient 7    371                228                         Undetectable             192
                                                                                       
  Patient 8    586                72                          71                       72
                                                                                       
  Patient 9    147                132                         Undetectable             96
                                                                                       
  Patient 10   428                72                          Undetectable             72
                                                                                       
  Patient 11   221                120                         Undetectable             48
                                                                                       
  Patient 12   445                96                          Undetectable             96

###### Demographic, laboratory and clinical data of the sample.

Mean age45 years (range: 32 to 65)GenderMale (n = 11)/female (n = 1)Side affectedBilateral (n = 6)/unilateral (n = 6)Mean CD4 lymphocyte count454 cells/ml (147 to 892)Viral loadUndetectable (n = 9)Mean length of time with HIV131 months (72 to 228)Mean length of time using antiretroviral therapy131 months (72 to 192)[^1]

###### WOMAC score before the operation and after six and twelve months of follow-up, and presence of dyslipidemia and lipodystrophy.

PatientWOMAC score before operation and after six and 12 months of follow-up (before/six/twelve)DyslipidemiaLipodystrophy171/21/3++289/19/19−+366/19/13++445/7/7−−573/32/15+−664/26/16++748/24/1++846/15/1++964/17/13++1080/34/26+−1157/4/4+−1268/14/6−+

[^1]: ^\*^TARV = terapia antirretroviral.
